13G Filing: EcoR1 Capital and Kura Oncology Inc (KURA)

Page 1 of 8

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
EcoR1 Capital 0 3,766,852 0 3,766,852 3,766,852 13.6%
Oleg Nodelman 0 3,766,852 0 3,766,852 3,766,852 13.6%
EcoR1 Capital Fund Qualified 0 3,057,191 0 3,057,191 3,057,191 11.0%

Follow Oleg Nodelman's EcoR1 Capital

Page 1 of 8 – SEC Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. 4)

Kura Oncology, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

50127T109

(CUSIP Number)

August 11, 2017

(Date of Event Which Requires Filing of this
Statement)

Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:

[ X ]       Rule 13d-1(b)

[ X ]       Rule 13d-1(c)

[ ]       Rule
13d-1(d)

* The remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing
information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall
not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).

Potential persons who are to respond to the collection of information
contained in this form are not required to respond unless the form displays a currently valid OMB control number.

1

Follow Kura Oncology Inc. (NASDAQ:KURA)


Page 1 of 8